PRX, ALKS, Initiated At Buy

Joe Young

September 30, 2010 10:23am Comments

UBS has initiated coverage for the following companies:

Par Pharmaceutical Companies (NYSE: PRX) Buy, $35 price target

Alkermes Inc. (NASDAQ: ALKS) Buy, $18 price target

Posted-In: alkermes par pharmaceutical UBS Initiation Analyst Ratings

Need analyst data?
Click here to see licensing options.

Stock	Firm	Action	PT
SEDG	B of A Securities	Maintains	411.0
PTLO	Piper Sandler	Maintains	28.0
AOUT	Lake Street	Maintains	26.0
RAPT	Piper Sandler	Maintains	52.0
OCX	Lake Street	Maintains	6.0

1	Trump Toasts Tariff Victory As Economists Quietly Junk Their Trade Forecasts
2	BCS, MSTR: Strategy Closes $2.52B STRC IPO, Acquires 21,021 Bitcoin At $117K Each
3	AMZN, BMY: Dow Falls Over 150 Points After Powell's Comments On Rate...
4	UNH: UnitedHealth Hit By $6.5 Billion Medical Cost Blowout: Laun...
5	THG, UVE: 5 Undervalued Dividend Stocks To Buy As Rally Gets...
6	UPS, QCOM: Stock Market Today: S&P 500, Nasdaq To...
7	UUP: Trump's Inflation Honeymoon Is Ove...

1	RACE: Ferrari Stock Slides On Q2 Earnings: The Details
2	HWM: Howmet Aerospace Posts Record Profit, Raises 2025 Outlook
3	TAP, CGC: Tilray's Unique Strategy Could Make It A Winner As Cannabis,...
4	$USDT, $BTC: Tether Posts $4.9B Profit, Surpasses $127B In U.S. Tre...
5	CRWV: CoreWeave (CRWV) Stock Is Surging Thursday: What&#...
6	SYK: If You Invested $100 In This Stock 20 Years Ago...
7	PGR, INDA: Two Trump Policies The Market Hasn...

Market Overview